Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure

被引:1
|
作者
Noda, Takumi [1 ,2 ]
Kamiya, Kentaro [1 ,3 ,9 ]
Hamazaki, Nobuaki [4 ]
Nozaki, Kohei [4 ]
Ichikawa, Takafumi [4 ]
Yamashita, Masashi [1 ,5 ]
Uchida, Shota [1 ]
Maekawa, Emi [6 ]
Terada, Tasuku [2 ]
Reed, Jennifer L. [2 ,7 ,8 ]
Yamaoka-Tojo, Minako [1 ,3 ]
Matsunaga, Atsuhiko [1 ,3 ]
Ako, Junya [6 ]
机构
[1] Kitasato Univ, Dept Rehabil Sci, Grad Sch Med Sci, Sagamihara, Japan
[2] Univ Ottawa, Div Cardiac Prevent & Rehabil, Exercise Physiol & Cardiovasc Hlth Lab, Heart Inst, Ottawa, ON, Canada
[3] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Japan
[4] Kitasato Univ Hosp, Dept Rehabil, Sagamihara, Japan
[5] ARCE Inc, Div Res, Sagamihara, Japan
[6] Kitasato Univ, Dept Cardiovasc Med, Sch Med, Sagamihara, Japan
[7] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[8] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada
[9] Kitasato Univ, Dept Rehabil, Sch Allied Hlth Sci, 1-15-1 Kitasato,Minami Ku, Sagamihara, Kanagawa 2520375, Japan
关键词
Cardio-hepatic syndrome; Heart failure; Liver dysfunction; Renal dysfunction; Frailty; CHRONIC KIDNEY-DISEASE; LIVER-FUNCTION TESTS; MELD SCORING SYSTEM; HEPATIC-DYSFUNCTION; OLDER-ADULTS; TRANSPLANTATION; SURVIVAL; MUSCLE; EXERCISE; XI;
D O I
10.1016/j.jjcc.2022.08.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Complex multi-organ interactions such as coexistence of hepato-renal dysfunction in heart failure (HF) adversely affects patient prognosis. However, the association between liver/kidney dysfunction and frailty and effects of their coexistence on HF prognosis remain unclear.Methods: This retrospective cohort study included 922 patients with HF (median age, 72 years; interquartile range: 62-79 years). All patients underwent hepato-renal function testing using the model for end-stage liver disease, excluding international normalized ratio (MELD-XI) score and frailty score. Frailty was measured using a composite of four markers: handgrip strength, gait speed, serum albumin, and activities of daily living status, combined into a total frailty score (range 0-12). Patients were assigned to a frailty score <5 (without frailty) or >= 5 (frailty) group. The multivariable logistic regression model was used to analyze the association between MELD-XI score and frailty; the prognostic value of high MELD-XI score and frailty coexistence was investigated. The endpoint was all-cause mortality.Results: After adjusting for covariates and dividing by the median MELD-XI score, the high MELD-XI score group [odds ratio: 1.663, 95 % confidence interval (CI): 1.200-2.304, p = 0.002] was significantly associated with frailty, compared with the low MELD-XI score group. One hundred and fifty deaths occurred during follow-up (median, 2.13 years; interquartile range, 0.93-4.09 years). Patients in the high MELD-XI score/frailty group had a significantly higher mortality risk, even after adjusting for HF severity (hazard ratio: 4.326, 95 % CI: 2.527-7.403, p < 0.001).Conclusions: Hepato-renal dysfunction is associated with frailty in patients with HF, which affects patient prognosis.Brief summary: This study showed that hepato-renal dysfunction in patients with HF, as assessed by the model for end-stage liver disease excluding international normalized ratio (MELD-XI) score, is associated with frailty, even after adjusting for factors involved in the frailty or severity of HF. Additionally, high MELD-XI score combined with frailty is associated with a poorer prognosis. These results suggest that hepato-renal dysfunction and frailty can be used for risk stratification in patients with HF.(c) 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:215 / 221
页数:7
相关论文
共 50 条
  • [21] Model for end-stage liver disease excluding normalized ratio (MELD-XI) score as a measure of hepato-renal dysfunction in patients with decompensated heart failure
    Gomez Madronero, L. M.
    Moraes, L. R.
    Terhoch, C. B.
    Moreira, H. F.
    Ayub-Ferreira, S. M.
    Oliveira, M. T.
    Lage, S. G.
    Issa, V. S.
    Bocchi, E. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 365 - 366
  • [22] Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
    Dager, WE
    White, RH
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) : 1232 - 1236
  • [23] Clinical and prognostic significance of renal dysfunction in stable patients with chronic heart failure
    Jankowska, E. A.
    Witkowski, T.
    Tomkiewicz-Pajak, L.
    Podolec, P.
    Banasiak, W.
    Ponikowski, P.
    EUROPEAN HEART JOURNAL, 2005, 26 : 419 - 420
  • [24] Prognostic impact of nutrition measures in patients with heart failure varies with coexisting physical frailty
    Iida, Yuki
    Kamiya, Kuniyasu
    Adachi, Takuji
    Iwatsu, Kotaro
    Kamisaka, Kenta
    Iritani, Naoki
    Imoto, Shota
    Yamada, Sumio
    ESC HEART FAILURE, 2023, 10 (06): : 3364 - 3372
  • [25] The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients
    Abe, Takuro
    Jujo, Kentaro
    Maeda, Daichi
    Saito, Katsumi
    Ogasahara, Yuki
    Saito, Kazuya
    Saito, Hiroshi
    Iwata, Kentaro
    Konishi, Masaaki
    Kitai, Takeshi
    Kasai, Takatoshi
    Wada, Hiroshi
    Momomura, Shin-ichi
    Kagiyama, Nobuyuki
    Kamiya, Kentaro
    Yamashita, Masashi
    Hamazaki, Nobuaki
    Nozaki, Kohei
    Maekawa, Emi
    Ako, Junya
    Matsue, Yuya
    ESC HEART FAILURE, 2023, 10 (03): : 1698 - 1705
  • [26] Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction
    Sunaga, Akihiro
    Hikoso, Shungo
    Yamada, Takahisa
    Yasumura, Yoshio
    Uematsu, Masaaki
    Tamaki, Shunsuke
    Abe, Haruhiko
    Nakagawa, Yusuke
    Higuchi, Yoshiharu
    Fuji, Hisakazu
    Mano, Toshiaki
    Kurakami, Hiroyuki
    Yamada, Tomomi
    Kitamura, Tetsuhisa
    Sato, Taiki
    Oeun, Bolrathanak
    Kida, Hirota
    Kojima, Takayuki
    Sotomi, Yohei
    Dohi, Tomoharu
    Okada, Katsuki
    Suna, Shinichiro
    Mizuno, Hiroya
    Nakatani, Daisaku
    Sakata, Yasushi
    ESC HEART FAILURE, 2021, 8 (04): : 3316 - 3326
  • [27] Clinical Impact of Renal Dysfunction in Heart Failure
    Palazzuoli, Alberto
    Beltrami, Matteo
    Nodari, Savina
    McCullough, Peter A.
    Ronco, Claudio
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2011, 12 (04) : 186 - 199
  • [28] Prognostic impact of renal and hepatic dysfunction based on the MELD-XI score in patients with acute heart failure
    Inohara, Taku
    Kohsaka, Shun
    Shiraishi, Yasuyuki
    Goda, Ayumi
    Sawano, Mitsuaki
    Yagawa, Mayuko
    Mahara, Keitaro
    Fukuda, Keiichi
    Yoshikawa, Tsutomu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 571 - 573
  • [30] Prognostic impact of subclinical thyroid dysfunction in heart failure
    Frey, Anna
    Kroiss, Matthias
    Berliner, Dominik
    Seifert, Marina
    Allolio, Bruno
    Gueder, Guelmisal
    Ertl, Georg
    Angermann, Christiane E.
    Stoerk, Stefan
    Fassnacht, Martin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 300 - 305